← Evidence map

ArticleLung cancer (Amsterdam, Netherlands)2025

Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919].

Jessica R Bauman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Corrigendum to "Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer" [Lung Cancer 195 (2024) 107919]. | Socratic